Latest & greatest articles for overdiagnosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on overdiagnosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on overdiagnosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for overdiagnosis

1. Overdiagnosis

Overdiagnosis Top results for overdiagnosis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for overdiagnosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

2. Overdiagnosis: what it is and what it isn?t Full Text available with Trip Pro

Overdiagnosis: what it is and what it isn?t Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis: what it is and what it isn’t Article Text Editorial Overdiagnosis: what it is and what it isn’t Free John Brodersen , , Lisa M Schwartz , Carl Heneghan , Jack William O’Sullivan , Jeffrey K Aronson , Steven Woloshin Statistics from Altmetric.com Why then, can one desire too much

2018 Evidence-Based Medicine

3. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 Cancer Australia

4. A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month

A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month By on October 13, 2016. I knew it. I just knew it. I knew I couldn’t get through October, a.k.a. Breast Cancer Awareness Month, without a controversial (...) mammography study to sink my teeth into. And I didn’t. I suppose I should just be used to this now. I’m referring to the latest opus from H. Gilbert Welch and colleagues that appeared in the New England Journal of Medicine last night, . Yes, it’s about overdiagnosis, something I’ve blogged about more times than I can remember now, but it’s actually a rather interesting take on the issue. Before 2008 or so, I never gave that much thought to the utility of mammographic screening as a means of early

2016 Respectful Insolence

5. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. Full Text available with Trip Pro

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. To quantify the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.Modelling and validation of the lifetime risk method using publicly available population data.Opportunistic screening for prostate cancer in the Australian population.Australian (...) male population (1982-2012).Prostate-specific antigen testing for prostate cancer screening.Primary: lifetime risk of overdiagnosis in 2012 (excess lifetime cancer risk adjusted for changing competing mortality); Secondary: lifetime risk of prostate cancer diagnosis (unadjusted and adjusted for competing mortality); Excess lifetime risk of prostate cancer diagnosis (for all years subsequent to 1982).The lifetime risk of being diagnosed with prostate cancer increased from 6.1% in 1982 (1 in 17

2019 BMJ open

6. The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma Full Text available with Trip Pro

The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma The 2015 guidelines from the American Thyroid Association for adults with thyroid nodules and differentiated thyroid may be particularly important in minimising potential harm from overdiagnosis and overtreatment of thyroid tumours by providing more restrictive indications for biopsy of thyroid

2018 European Endocrinology

7. Overdiagnosis in primary care: framing the problem and finding solutions. Full Text available with Trip Pro

Overdiagnosis in primary care: framing the problem and finding solutions. Overdiagnosis, is defined as the diagnosis of a condition that, if unrecognized, would not cause symptoms or harm a patient during his or her lifetime, and it is increasingly acknowledged as a consequence of screening for cancer and other conditions. Because preventive care is a crucial component of primary care, which is delivered to the broad population, overdiagnosis in primary care is an important problem from (...) a public health perspective and has far reaching implications. The scope of overdiagnosis as a result of services delivered in primary care is unclear, though overdiagnosis of indolent breast, prostate, thyroid, and lung cancers is well described and overdiagnosis of chronic kidney disease, depression, and attention-deficit/hyperactivity disorder is also recognized. However, overdiagnosis is a known consequence of all screening and can be assumed to occur in many more clinical contexts. Overdiagnosis

2018 BMJ

8. Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis. Full Text available with Trip Pro

Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis. To describe the lived experience of a possible prostate cancer overdiagnosis in men who resisted recommended treatment.Qualitative interview study SETTING: Australia PARTICIPANTS: 11 men (aged 59-78 years) who resisted recommended prostate cancer treatment because of concerns about overdiagnosis and overtreatment.Reported experience of screening, diagnosis and treatment (...) through treatment decision making. This often led them to develop a sense of disillusionment and distrust towards the medical profession and conventional medicine. The findings show how some men who were told they would soon die without treatment (a prognosis which ultimately did not eventuate) reconciled issues of overdiagnosis and potential overtreatment with their own diagnosis and situation over the ensuing 1 to 20+ years.Men who choose not to have recommended treatment for prostate cancer may

2019 BMJ open

9. Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. (Abstract)

Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. Shared patient-physician decision-making regarding treatment for prostate cancer detected by prostate-specific antigen screening involves a complex calculus weighing the risk of the cancer and patient life expectancy. We investigated quantifying these competing risks using the probability that the cancer was "overdiagnosed"-i.e., would not have been (...) clinically diagnosed (diagnosed without screening) during the patient's remaining lifetime.Using an established model of prostate cancer screening and clinical diagnosis, we simulated screen-detected cases and determined whether modeled clinical diagnosis would occur before non-cancer death, which was based on comorbidity-adjusted population lifetables. Logistic regression models were fitted to the simulated data and used to estimate overdiagnosis probabilities given patient age, PSA level, Gleason sum

2019 Journal of Urology

10. THESIS: Preventing Overdiagnosis, the Quaternary Prevention

THESIS: Preventing Overdiagnosis, the Quaternary Prevention THESIS: Preventing Overdiagnosis, the Quaternary Prevention — Less is More Medicine Discover Act About Nanaimo BC Phone Number Putting the focus on effective, appropriate, and good-value healthcare Your Custom Text Here March 20, 2018 Maria Llargués Pou, a soon-to-be Family Physician in Barcelona, recently shared with me her Bachelor's Thesis. Her work - "Primum non nocere " Preventing Overdiagnosis, the Quaternary Prevention provides (...) , contemporary efforts to tackle overdiagnosis, like the Choosing Wisely Campaign and Preventing Overdiagnosis conference. Her paper serves as a great "backgrounder" for those who wish to learn more about the broad themes and history of this movement. You can view the full text In , , Tags , , , , , , , articles and Original Commentary on the topic of "Less is More in Medicine" and The "Right Care" SITE SEARCH: SUBSCRIBE: E-mail updates: SIMILAR BLOGS: (ES) (not affiliated) (BP) CATEGORIES: TWEETS: RT

2018 Less is More in Medicine Blog

11. Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Full Text available with Trip Pro

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Screening for prostate cancer is frequent in high-income countries, including Switzerland. Notably due to overdiagnosis and overtreatment, various organisations have recently recommended against routine screening, potentially having an impact on incidence, mortality, and surgery rates. Our aim was therefore to examine whether secular trends in the incidence and mortality (...) and prostatectomy observed in Switzerland among men younger than 70 years have concomitantly leveled off around 2002/2003. Given the decreasing mortality, these trends may reflect recent changes in screening and clinical workup practices, with a possible attenuation of overdiagnosis and overtreatment.

2019 PLoS ONE

12. Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis

Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Article Text Therapeutics/Prevention Observational study US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Rebecca A Hubbard Statistics from Altmetric.com Commentary on: Harding C , Pompei F , Burmistrov D , et al . Breast Cancer Screening, Incidence

2015 Evidence-Based Medicine

13. Overdiagnosis of COPD in subjects with unobstructed spirometry - a BOLD analysis. Full Text available with Trip Pro

Overdiagnosis of COPD in subjects with unobstructed spirometry - a BOLD analysis. There are several reports on underdiagnosis of COPD, while little is known about COPD overdiagnosis and overtreatment. We describe the overdiagnosis and the prevalence of spirometrically defined false positive COPD, as well as their relationship with overtreatment across 23 population samples in 20 countries participating in the BOLD Study between 2003 and 2012.A false positive diagnosis of COPD was considered (...) when participants reported a doctor's diagnosis of COPD, but postbronchodilator spirometry was unobstructed (FEV1/FVC > LLN). Additional analyses were performed using the fixed ratio criterion (FEV1/FVC < 0.7).Among 16,177 participants, 919 (5.7%) reported a previous medical diagnosis of COPD. Postbronchodilator spirometry was unobstructed in 569 subjects (61.9%): false positive COPD. A similar rate of overdiagnosis was seen when using the fixed ratio criterion (55.3%). In a subgroup analysis

2019 Chest

14. Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey. Full Text available with Trip Pro

Comparing perceived clarity of information on overdiagnosis used for breast and prostate cancer screening in England: an experimental survey. 'Overdiagnosis', detection of disease that would never have caused symptoms or death, is a public health concern due to possible psychological and physical harm but little is known about how best to explain it. This study evaluated public perceptions of widely used information on the concept to identify scope for improving communication (...) methods.Experimental survey carried out by a market research company via face-to-face computer-assisted interviews.Interviews took place in participants' homes.2111 members of the general public in England aged 18-70 years began the survey; 1616 were eligible for analysis. National representativeness was sought via demographic quota sampling.Participants were allocated at random to receive a brief description of overdiagnosis derived from written information used by either the NHS Breast Screening Programme

2017 BMJ open

15. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. (Abstract)

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Effective breast cancer screening should detect early-stage cancer and prevent advanced disease.To assess the association between screening and the size of detected tumors and to estimate overdiagnosis (detection of tumors that would not become clinically relevant).Cohort study.Denmark from 1980 to 2010.Women aged 35 to 84 years.Screening programs offering biennial mammography for women aged 50 to 69 years (...) beginning in different regions at different times.Trends in the incidence of advanced (>20 mm) and nonadvanced (≤20 mm) breast cancer tumors in screened and nonscreened women were measured. Two approaches were used to estimate the amount of overdiagnosis: comparing the incidence of advanced and nonadvanced tumors among women aged 50 to 84 years in screening and nonscreening areas; and comparing the incidence for nonadvanced tumors among women aged 35 to 49, 50 to 69, and 70 to 84 years in screening

2017 Annals of Internal Medicine

16. Overdiagnosis from mammographic screening

Overdiagnosis from mammographic screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 MHRA Drug Safety Update

17. Sayer Ji: Willfully misunderstanding overdiagnosis and misdiagnosis since…forever

Sayer Ji: Willfully misunderstanding overdiagnosis and misdiagnosis since…forever Sayer Ji: Willfully misunderstanding overdiagnosis and misdiagnosis since...forever | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation Sayer Ji: Willfully misunderstanding overdiagnosis and misdiagnosis since...forever By on May 1, 2016. If there's one lesson that I like to emphasize while laying down my near-daily dose of Insolence, both Respectful and not-so-Respectful, it's (...) . Ji seems to mean the . Most recently, he has appeared on the deeply dishonest "documentary" about alternative medicine cancer cures, , to expound on how chemotherapy is evil. His rant about the reclassification of a non-encapsulated follicular variant of papillary thyroid cancer as not cancer is more of the same, as you will see. Overdiagnosis and the question of what is and isn't "cancer"? The sort of issue mangled by Mr. Ji in his article is one that those of us who treat breast cancer have

2016 Respectful Insolence

18. Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Full Text available with Trip Pro

Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Article Text Letter Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn ’ t ’ Wendy A Rogers 1 , 2 , Yishai Mintzker 3 Statistics from

2018 Evidence-Based Medicine

19. Overdiagnosis and lives saved due to reflex testing men with intermediate prostate-specific antigen levels. (Abstract)

Overdiagnosis and lives saved due to reflex testing men with intermediate prostate-specific antigen levels. Several prostate cancer early detection biomarkers are available for reflex testing in men with intermediate prostate-specific antigen (PSA) levels. Studies of these biomarkers typically provide information about diagnostic performance but not about overdiagnosis and lives saved, the primary drivers of associated harm and benefit.We projected overdiagnoses and lives saved using

2019 Journal of the National Cancer Institute

20. Lyme Disease Overdiagnosis in a Large Healthcare System: A Population-based, Retrospective Study. (Abstract)

Lyme Disease Overdiagnosis in a Large Healthcare System: A Population-based, Retrospective Study. To evaluate the impact of false positive IgM immunoblots on Lyme disease treatment and case reporting in a large healthcare system.We obtained results of all Lyme disease serologic tests ordered at U.S. Air Force healthcare facilities in the United States between January 2013 and December 2017. We conducted chart reviews to adjudicate positive IgM immunoblots (from two-tier and independent testing

2019 Clinical Microbiology and Infection